Advance Zinctek Limited · ASX:ANO
Advance Zinctek — Shareholder Meeting (October 2024)
16 slides from Advance Zinctek's shareholder meeting presentation, Oct 14, 2024
Slide 1: Advance ZincTek Ltd Market Update October 2024
For personal use only Advance ZincTek Ltd Market Update October 2024 9 for ANO: ‘Appointed March 2016
Slide 2: Federal Court Action - Veganic SKN Ltd
For personal use only Federal Court Action - Veganic SKN Ltd The proceedings commenced by Veganic SKN Ltd allege that Cancer Council Australia has and continues to engage in misleading conduct in respect of the Chemical UV filters contained in the sunscreens that it sells and promotes. This conduct
Slide 3: Impact of Inferior Imported Zinc Oxide Powders
For personal use only Impact of Inferior Imported - Zinc Oxide Powders * Quote from the TGA - “The TGA does not currently require sponsors to submit details of the GMP Compliance for active ingredients used in listed medicines, as this step is not recorded in the application at the time of listing o
Slide 4: Imported Zinc Oxide Powders Not Compliant with Monographs (BP/USP)
For personal use only Imported - Zinc Oxide Powders Not Compliant with Monographs (BP/ USP) ZINC OXIDE MONOGRAPH RAPE IMPORTED | REQUIREMENTS/SPECIFICATIONS COA Ts Gen FROM OF BRITISH PHARMACOPOEIA (BP) ‘SPECIFICATIONS SPECIFICATIONS OF USP NF ‘SPECIFICATIONS 2024 Ind Thallium Limit: Max Sppm. Thall
Slide 5: Recent UV Filter Developments
For personal use only Recent UV Filter Developments Australian Limit EU Limit (18g per a OUR? (140ml per a day) day) etn 4-MBC * 4% BANNED BANNED Homosalate 15% 0.5% 10% Oxyenzone 10% 2.2% 6% Homosalate = 240 times greater exposure for Australians vs EU. Maximum “Evidence suggests potential endocrin
Slide 6: MBC/Enzacamene: 2022 European Union SCCS Review Highlighted
For personal use only 4 MBC/ Enzacamene: 2022 European Union SCCS Review Highlighted 1 Endocrine Disruption “Evidence suggests potential endocrine disruption and carcinogenicity at higher concentrations." \ / ( >» 2 Bioaccumulation "Increased dermal absorption values and recalculated systemic exposu
Slide 7: Brisbane Production Capacity (Active Ingredients)
For personal use only Brisbane Production Capacity (Active Ingredients) XP Powder e From 75 cents per 100g tube based on 25% Zinclear®XP Powder e 5000 MT per annum (STD 1 shift). ¢ Equivalent of > 200,000,000 100g tubes of sunscreen > (SPF 30). ¢ Sufficient to produce. 24 Zinc Based Dispersions Tota
Slide 8: New Dispersions | New Sunscreens
For personal use only 20 New Dispersions | 17 New Sunscreens Oil AB MCT JJ Sunflower Coco Caprylate Dispersion Sunscreen Recipe Name Name ZinClear®XP65A ABsD OBSA XP65A AB+D ZinClear®XP6SMCT MCT10 Sunscreen ZinClear®XPA_XP6 OBSA AE XPA_XP61JJE ZinClear® XP50 Sunflower Blended Base 600 Alusion ZinCle
Slide 9: New Dispersions | New Sunscreens Coming Soon
New Dispersions | New Sunscreens Coming Soon. For personal use only DISPERSIONS UNDER SUNSCREEN RECIPE SUNSCREEN IN VIVO SUNSCREEN IN VITRO DEVELOPMENT NAME RESULT 10/ PERSON RESULT 369 APRICOT OBSA_XP65APRP 45 (Final) HEMP 347 OBSA_XP6SHEMP (5 people only) 49.91 ANTA
Slide 10: Key Highlights 2024
For personal use only Key Highlights 2024 Distributor Network Location 2023 2024 % Increase Countries USA/ Canada 1 4 300% 2 Europe 7 11 57% 23 Asia 6 11 83% 10 South America 1 4 300% 4 Total: 15 30 Up 100% 39 Australian/ New 36 34 2 Zealand Customers ANTARIA
Slide 11: Items in November 2023 Target vs 2024 Delivered
For personal use only Items in Investor Presentation 2023 November | 2023 | Target | 2024 | Delivered © Continue to grow the number of distributors in Europe, Asia * 3new distributors in USA/ Canada. and South America. ¢ 4new distributors in Europe. ¢ 5 new distributors in Asia. © 3 new distributors
Slide 12: Sales and Profit Comparison
Sales and Profit Comparison 2024-2025 FY24 sales in the first half of FY25.” * Clarification to the Chairman's letter FY24. “We are likely to match our total USA a, Cc ro) FY 24 FY 25 o op) Total Actual sales to $2,812,285 $2,715,860 a) October 10, 2025 “ “ © Cc o) n Profit before tax $106,862 $114,
Slide 13: Consolidation of Operations - Electricity and Wages
For personal use only Consolidation of Operations Expenses (expected savings of up to $1M) Electricity $163,684 FY23 Wages 93,029,044 Fy23 $143,089 FY24 $2,773,368 Fy28 $8,626 3 Months To September 30, 2025 $492,089 3 Months to September 30, 2025 ¢ Perth electricity represented 58.66% of FY23 and FY
Slide 14: Consolidation of Operations - Transport and Rent
For personal use only Consolidation of Operations Expenses (expected savings of up to $1M) Transport to Perth $72,890 $69,599 * Nil containers to and from Perth for XP powder, IM powder and raw ingredients. $0 Fr28 Fy24 3 Months To September 30, 2025 Rent 5637757 9671,619 Rent in Perth: * Charles St
Slide 15: Consolidation of Operations - Workers Compensation and Insurance
For personal use only ADVANTE ZINCTEK LTD Consolidation of Operations Expenses (expected savings of up to $1M) Workers Compensation/ Payroll Tax $241,965 $247,757 $40,438 $5,373 ¥23 FY24 Brisbane Perth, 3 Months to September 30, 2025 Insurance $249,367 $208,921 $157,250 FY23 FY24 Annual Insurance Ex
Slide 16: Disclosures Regarding Forward Looking Statements
For personal use only Disclosures Regarding Forward Looking Statements * This Market Statement includes forward-looking statements based on current expectations and predictions about future events including Advance ZincTek's intentions. * These forward-looking statements are, subject to inherent ris